S100A4 mRNA as a prognostic marker and therapeutic target in Wilms tumor (WT).
暂无分享,去创建一个
[1] Shan Li,et al. Clinicopathological and prognostic significance of S100A4 overexpression in colorectal cancer: a meta-analysis , 2013, Diagnostic Pathology.
[2] Hua Zhang,et al. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma , 2013, Journal of Clinical Pathology.
[3] X-J Gao,et al. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF. , 2013, European review for medical and pharmacological sciences.
[4] K. Zhao,et al. RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway. , 2013, European review for medical and pharmacological sciences.
[5] Jun Liang,et al. Clinicopathological significance of S100A4 expression in human hepatocellular carcinoma , 2013, The Journal of international medical research.
[6] Li Liu,et al. S100A4 siRNA inhibits human pancreatic cancer cell invasion in vitro. , 2012, Biomedical and environmental sciences : BES.
[7] Y. Song,et al. Evaluation of Plasma and Tissue S100A4 Protein and mRNA Levels as Potential Markers of Metastasis and Prognosis in Clear Cell Renal Cell Carcinoma , 2012, The Journal of international medical research.
[8] Xu Ma,et al. Small interfering RNA-directed knockdown of S100A4 decreases proliferation and invasiveness of osteosarcoma cells. , 2010, Cancer letters.
[9] H. Fu,et al. Short hairpin RNA-mediated inhibition of S100A4 promotes apoptosis and suppresses proliferation of BGC823 gastric cancer cells in vitro and in vivo. , 2010, Cancer letters.
[10] K. Ohuchida,et al. S100A4 mRNA is a Diagnostic and Prognostic Marker in Pancreatic Carcinoma , 2009, Journal of Gastrointestinal Surgery.
[11] S. Kageyama,et al. Significance of S100A4 as a prognostic marker of lung squamous cell carcinoma. , 2009, Anticancer research.
[12] T. Hla,et al. S1P/S1P1 signaling stimulates cell migration and invasion in Wilms tumor. , 2009, Cancer letters.
[13] K. Kandil,et al. Serum metastasin mRNA is an important survival predictor in breast cancer , 2008, British journal of biomedical science.
[14] Mohammad Saleem,et al. S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9 , 2006, Proceedings of the National Academy of Sciences.
[15] P. Jurasz,et al. Generation of platelet angiostatin mediated by urokinase plasminogen activator: effects on angiogenesis , 2006, Journal of thrombosis and haemostasis : JTH.
[16] S. Leinster,et al. Association of S100A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.
[17] David J Weber,et al. S100A4, a Mediator of Metastasis* , 2006, Journal of Biological Chemistry.
[18] N. Breslow,et al. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] Yohko Nakamura,et al. Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cells , 1997, Oncogene.
[20] E. Hovig,et al. Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme. , 1996, Cancer research.
[21] M. Grigorian,et al. Effect of mts1 (S100A4) expression on the progression of human breast cancer cells , 1996, International journal of cancer.
[22] K. Kawakami,et al. Different factors bind to the regulatory region of the Na+,K+‐ATPase α1‐subunit gene during the cell cycle , 1993, FEBS letters.
[23] P. Rudland,et al. Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1. , 1993, Oncogene.
[24] M. Grigorian,et al. Isolation and characterization of a gene specifically expressed in different metastatic cells and whose deduced gene product has a high degree of homology to a Ca2+-binding protein family. , 1989, Genes & development.